Opentrons IPO
Opentrons is a life sciences company that develops automated laboratory equipment and software for scientific research. The company's robotic platforms enable researchers to automate pipetting, sample preparation, and other laboratory workflows, making scientific experiments more reproducible and efficient.
Key Facts
| Industry | Laboratory Automation |
| Founded | 2013 |
| Headquarters | Brooklyn, NY |
| Employees | ~400 |
| Website | opentrons.com |
| Funding | Series C funding. Total raised: $112M |
About Opentrons
Opentrons develops accessible laboratory automation systems designed to make precision liquid handling available to researchers worldwide. The company's flagship products include pipetting robots and automated laboratory equipment that can be programmed through an open-source software platform. Opentrons' systems are significantly more affordable than traditional lab automation solutions, making advanced robotics accessible to smaller research labs and educational institutions.
The company gained significant recognition during the COVID-19 pandemic when its robots were widely deployed for automated PCR testing and vaccine research. Opentrons' open-source approach allows researchers to share protocols and customize automation workflows, creating a collaborative ecosystem around laboratory automation. The platform supports a wide range of applications including drug discovery, synthetic biology, and diagnostic testing, positioning Opentrons as a democratizing force in life sciences research.
IPO Status
Opentrons has not announced any plans for an initial public offering. The company has established itself as a significant player in laboratory automation, particularly among academic and research institutions, and has raised venture funding to expand its product offerings and market reach. The life sciences tools sector has seen strong investor interest, especially following increased focus on laboratory infrastructure during the pandemic. However, Opentrons appears focused on product development and market expansion rather than pursuing public markets in the near term. The company would likely need to demonstrate broader commercial adoption and consistent profitability before considering an IPO.
Competitors
Frequently Asked Questions
Does Opentrons have a stock?
No, Opentrons has not had an IPO and remains a private life sciences company. The laboratory automation company has not announced plans to go public.
When is the Opentrons IPO date?
Opentrons has not announced an IPO date or timeline. The company remains private with no confirmed public offering plans.
How can I buy Opentrons stock?
Opentrons stock cannot be purchased as the company is still private. Retail investors would need to wait for a potential future IPO.
Stay Updated on the Opentrons IPO
Get real-time alerts when Opentrons files for an IPO, prices shares, or begins trading.
Get IPO Alerts